SURGICAL TREATMENT CHARACTERISTICS AND TACTICAL OPTIMIZATION FOR GIANT AND SUBSTERNAL GOITER: A FIVE-YEAR INSTITUTIONAL EXPERIENCE
Keywords:
post-operativeAbstract
Giant and substernal goiters remain major surgical entities requiring comprehensive tactical management due to their anatomical migration into the mediastinum, complex vascular architecture, and high risk of respiratory and vascular compression.
References
1.Randolph, G. W. (2020). Surgery of the Thyroid and Parathyroid Glands. Elsevier Health Sciences, pp. 112-130.
2.Bland, K. I., et al. (2018). General Surgical Operations. McGraw-Hill Medical, New York, pp. 245-260.
3.Galperin, E. I., & Vetshev, P. S. (2009). Retrosternal and intrathoracic goiters: clinical diagnostics and surgical tactical options. Surgery Journal, (2), 14-22.
4.Strasberg, S. M. (2015). Surgical access selection criteria in giant endocrine masses. World Journal of Surgery, 39(4), 881-889.
5.Shaha, A. R. (2005). Substernal goiter: what is the best surgical approach? Annals of Surgical Oncology, 12(8), 594-596.
6.Katlic, M. R., Wang, C. A., & Grillo, H. C. (1985). Substernal goiter. The Annals of Thoracic Surgery, 39(4), 391-399.
7.Torre, G., et al. (2012). Surgical management of retrosternal goiter: analysis of 237 cases. Acta Medica Mediterranea, 28, 281-285.
8.Nazyrov, F. G., & Irisov, O. T. (2021). Tactical optimization in giant nodular goiter surgery. Uzbekistan Medical Journal, (3), 33-41.




United Kingdom
Germany
France
Uzbekistan
Türkiye
Kazakhstan
Kyrgyzstan
Turkmenistan
Azerbaijan
India
Republic of Korea
Japan
United States of America
Kosovo
Italy
Spain
Poland
Netherlands
Belgium
Sweden
Norway
Finland
Denmark
Switzerland
Austria
Czech Republic
Hungary
Romania
Bulgaria
Greece
Portugal